← back to search

Ronald G. Stoller

University of Pittsburgh · US
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Neutropenia and Cancer Infections, PARP inhibition in cancer therapy, Cancer-related gene regulation, and Protein Degradation and Inhibitors.
h-index
31
citations
4,399
works
83
NIH funding
primary concept
email

Recent publications

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Cancer Chemotherapy and Pharmacology 2019cited by 38position: middledoi
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium
Journal of Clinical Oncology 2015cited by 177position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hussein Tawbi · The University of Texas MD Anderson Cancer Center1 papers (2019–2019)Paul S. Ritch · Medical College of Wisconsin1 papers (2015–2015)Marie Pouquet · UPMC Hillman Cancer Center1 papers (2019–2019)David P. Kelsen · Memorial Sloan Kettering Cancer Center1 papers (2015–2015)Edward Chu · Wake Forest University1 papers (2019–2019)Suresh S. Ramalingam · Emory University1 papers (2019–2019)Manish A. Shah · Cornell University1 papers (2015–2015)Margaret Kemeny · Queens Hospital Center1 papers (2015–2015)Shannon Puhalla · UPMC Hillman Cancer Center1 papers (2019–2019)Fei Ding · The First Affiliated Hospital, Sun Yat-sen University1 papers (2019–2019)Yungpo Bernard Su · Nebraska Methodist College1 papers (2015–2015)Yixing Jiang · Jinan University1 papers (2019–2019)Charles Henderson · University of Utah1 papers (2015–2015)Smitha Krishnamurthi · Cleveland Clinic1 papers (2015–2015)Leigh Klaus Swartz · UPMC Hillman Cancer Center1 papers (2019–2019)Athanassios Argiris · Hygeia Hospital1 papers (2019–2019)Leonard J. Appleman · University of Pittsburgh1 papers (2019–2019)Brian F. Kiesel · University of California, Davis1 papers (2019–2019)Taofeek K. Owonikoko · New Mexico Cancer Center1 papers (2019–2019)Chandra P. Belani · University of California, Davis1 papers (2019–2019)